Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal Domains
about
Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In VitroLeishmania donovani Nucleoside Hydrolase Terminal Domains in Cross-Protective Immunotherapy Against Leishmania amazonensis Murine InfectionA Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis.HisAK70: progress towards a vaccine against different forms of leishmaniosis.A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection.Leishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis.F1 Domain of the Leishmania (Leishmania) donovani Nucleoside Hydrolase Promotes a Th1 Response in Leishmania (Leishmania) infantum Cured Patients and in Asymptomatic Individuals Living in an Endemic Area of Leishmaniasis.Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNFα-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis.Targeted Immunology for Prevention and Cure of VL.NH36 and F3 Antigen-Primed Dendritic Cells Show Preserved Migrating Capabilities and CCR7 Expression and F3 Is Effective in Immunotherapy of Visceral Leishmaniasis.
P2860
Q28546699-252AC6DF-5A22-40C1-AF98-5DB2F07F5CBBQ33737949-C598409A-CD43-4C5E-AE93-C97721AF7D20Q35687444-A0656F2B-8A10-4B50-88FC-539F6630EFB9Q36361604-5E1DB01C-53F6-4814-A43C-46715F822E84Q37660825-E49080E8-2242-45B0-B869-9FA5AA17F7F5Q37681902-7DFCF7B3-8C5A-4CD4-A84C-6CEF545461E8Q38658902-5A5D8428-6ED7-48A9-AE03-8D12B9D566FAQ40061497-F49DDAE9-EDBA-432D-B6A8-A30393757EB1Q41558777-F449C01B-A8B9-4637-B881-C5DAB88F88BDQ54968645-E3B7BA76-9CDB-41A4-9352-423720E98670
P2860
Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal Domains
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Cross-Protective Immunity to L ...... ide Hydrolase Terminal Domains
@ast
Cross-Protective Immunity to L ...... ide Hydrolase Terminal Domains
@en
Cross-Protective Immunity to L ...... de Hydrolase Terminal Domains.
@nl
type
label
Cross-Protective Immunity to L ...... ide Hydrolase Terminal Domains
@ast
Cross-Protective Immunity to L ...... ide Hydrolase Terminal Domains
@en
Cross-Protective Immunity to L ...... de Hydrolase Terminal Domains.
@nl
prefLabel
Cross-Protective Immunity to L ...... ide Hydrolase Terminal Domains
@ast
Cross-Protective Immunity to L ...... ide Hydrolase Terminal Domains
@en
Cross-Protective Immunity to L ...... de Hydrolase Terminal Domains.
@nl
P2093
P2860
P356
P1476
Cross-Protective Immunity to L ...... ide Hydrolase Terminal Domains
@en
P2093
Alexandre Morrot
Daniele Crespo Gomes
Diana Bahia
Dirlei Nico
Elisangela Oliveira Freitas
Marcos Palatnik
Marcus Vinícius Alves-Silva
Mauricio M Rodrigues
P2860
P356
10.3389/FIMMU.2014.00189
P577
2014-05-01T00:00:00Z